MedPath

Postpolypectomy bleeding in patients undergoing colonoscopy on antiplatelet therapy

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0000458
Lead Sponsor
Soon Chun Hyang University Hospital Seoul
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

? The patients undergo monotherapy or dual therapy with aspirin or clopidogrel and the patients who are taking wafarin but, can substitute for aspirin during shor period of time.
Ex) Primary hypertension,Stable angina, transient ischemic stroke, Coronary artery disease(stable coronary artery disease, non-ST segment elevation MI)
? The patients who undergo colon polypectomy.
? The patients who are participate in this study and signed informed consent.

Exclusion Criteria

? Low platelet count <80,000/mm3 and prologned PT/APTT in laboratory examination
? The patients who have gastrointestinal malignancy
? The patients taking anticoagulation within 7 days before CPP
? The patinets who have high bleeding risk due to comorbid disease; HAS-BLED score 3 or more than 3, high risk of cerebrovasculr event(CHADS2 score 2 or more than 2)
? The patients who refuse the agreement with informed consent.

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding complication after colon polypecgtomy (immediate, acute, delayed/major, minor bleeding)
Secondary Outcome Measures
NameTimeMethod
Other complication after colon polypectomy, vascular event such as stroke, transient ischemic attack, thromboembolilsm
© Copyright 2025. All Rights Reserved by MedPath